STAT3 and cancer: However, since STAT3 deletion leads to decreased mitochondrial function and increased oxidative stress, a selective inhibition of its nuclear functions preserving mitochondrial activity may be beneficial in treating Y-P STAT3-driven cancer/drug resistance.